PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 38: Articles 18501-19000 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Removal of intra-uterine contraceptive devices with non-visible threads [letter]
  2. Report of the Seventh Annual Workshop in "Family Planning, Nutrition, and Primary Health Care for Africa: Program Design, Management, and Evaluation".
  3. Report of the Study Directors' Meeting of the Pilot Study on the Role of Community Communication Networks in the Acceptance and Continuance of Family Planning Practice, Chiang Mai, Thailand, 16-19 September 1986.
  4. Report on the Regional Workshop on Family Planning Logistics, Bogota, Colombia, January 26-31, 1986.
  5. Report on the Second Enterprise Program Sponsored Workshop: Family Planning in the Commercial Sector, October 7-10, 1986, Hilton International Hotel, Nairobi, Kenya.
  6. Report on the Second Working Group Meeting on Training Systems for Personnel and Volunteers of Programs for the Community-Based Distribution of Contraceptives, Miami Beach, Florida, September 8-12, 1986.
  7. Reproduction and family planning in Ethiopian society: a survey of existing knowledge and possible application in MCH/FP services.
  8. Reproduction and the family: the role of family planning.
  9. Reproductive behavior and family planning in rural regions of Honduras. [Generatives Verhalten und Familienplanung im landlichen Raum von Honduras.]
  10. Reproductive risk, part II: family planning and reproductive risk. [Riesgo reproductivo II: planificacion familiar y riesgo reproductivo.]
  11. Research on the determinants of contraceptive use dynamics: a note on priorities.
  12. Resolution of a contraceptive-steroid-induced hepatic adenoma with subsequent evolution into hepatocellular carcinoma.
  13. Resources allocation for family planning services: a cost analysis.
  14. Retinovascular complications associated with oral contraceptives. [Retinale vaskulare Komplikationen bei oralen Kontrazeptiva.]
  15. Return of fertility after discontinuation of oral contraceptives [letter]
  16. Return of fertility after discontinuation of oral contraceptives [letter]
  17. Return of fertility after discontinuation of oral contraceptives [letter]
  18. Return of fertility in women discontinuing injectable contraceptives.
  19. Reversible contraception for the 1980s.
  20. The right of doctors in certain cases to prescribe contraceptives lawfully to children under the age of 16 without a parent's consent] [editorial.
  21. The rights of minors, planned parenthood, and abortion in Italy.
  22. Risk factors for uterine fibroids: reduced risk associated with oral contraceptives [letter]
  23. Risk factors for uterine fibroids: reduced risk associated with oral contraceptives.
  24. Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. Authors reply [letter]
  25. Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives: a case-control study.
  26. Risking paternity: sex and contraception among adolescent males.
  27. Risks of contraception with intrauterine devices. [Risques de la contraception par appareil intra-uterin.]
  28. Risks of contraception: minipill. [Risiken der Kontrazeption: Minipille.]
  29. Risks of contraception: vascular diseases. [Risiken der Kontrazeption: Gefasserkrankungen.]
  30. Risks of postcoital contraception with a d-norgestrel/ethinylestradiol combination. [Risiken der postkoitalen Kontrazeption mit einer d-Norgestrel-Ethinylostradiol-Kombination.]
  31. The risks of the natural family planning methods. [Les risques des methodes de continence periodique.]
  32. The risky business of birth control.
  33. The role of communication in a maternal and child health project including family planning: the case of the Centre Santiaba de Ziguinchor. [Place de la communication dans un projet de sante maternelle et infantile y compris la planification familiale cas du Centre Santiba de Ziguinchor.]
  34. The role of community communication network on the acceptance and continuance of family planning practice. Prototype research design.
  35. Role of health delivery services in acceptance of family planning (phase I): a multi-centre study.
  36. Role of health delivery services in acceptance of family planning in Gujarat.
  37. The role of health delivery systems in the acceptance of family planning, India (Phase I), [Indian Council of Medical Research, Operations Research Group, Baroda, and Population Research Center, Baroda. Operations research project summary]
  38. The role of industry in family planning.
  39. The role of intrauterine contraceptive devices in the development of inflammatory processes in the small pelvis. [A mehen beluli fogamzasgatlo eszkozok szerepe a kismedencei gyulladasos folyamatok kialakulasaban.]
  40. The role of private family planning organization in Japan.
  41. The role of sterilization in Colombia's family planning program: a national debate.
  42. The role of the for-profit private sector in family planning in the Third World.
  43. The role of the organised sector in the family planning programme.
  44. The role of the private sector in family planning: a strategy for action. [El rol del sector privado en planificacion familiar: una estrategia para la accion.]
  45. Role of village practitioners in family planning delivery system, Bangladesh, [National Institute of Population Research and Training, NIPORT, Bangladesh, Operations Research Project summary]
  46. The role of women managers in family planning and population programs.
  47. Rumor, misinformation and oral contraceptive use in Egypt.
  48. Salivary antipyrine half-life during injectable progestagen contraception.
  49. The sample registration system: a microcomputer system for monitoring demographic dynamics and health and family planning service operations in rural Bangladesh.
  50. Satisfied IUD acceptors as family planning motivators in Sri Lanka.
  51. School physical program: an adolescent family planning clinic reaches out to boys.
  52. Screening examination of the liver focusing on the occurrence of adenoma in women using hormonal contraception. [Screeningove vysetreni jater se zamerenim na vyskyt adenomu u zen uzivajicich hormonalni antikoncepci.]
  53. Screening for cervical cancer: the role of contraception and of social class. [Depistage du cancer du col uterin: role de la contraception et de la categorie socio-professionnelle.]
  54. Selection criteria for oral contraceptive use: current concepts.
  55. Semen analysis as a tool in the search for a male contraceptive.
  56. Seminar on Utilizing Existing Infrastructure for Provision of Family Planning, Pattaya, Thailand, January 19th-25th, 1986; report.
  57. Serum vitamin B12 and folate levels in women taking oral contraceptives.
  58. Serving the people stressed in family planning.
  59. Sex hormones and related compounds including oral contraceptives.
  60. Sex preference, fertility, and family planning in China.
  61. Sexual activity and contraceptive habits among young people. An investigation among pupils in the ninth grade in the municipality of Viborg. [Seksuel aktivitet og praeventionsvaner blandt unge. En undersogelse blandt elever i 9. klasse i Viborg kommune.]
  62. Sexual behavior, contraceptive practice, and reproductive health among Nigerian adolescents.
  63. Sexual behaviour, perceptions of infertility and family planning in sub-Saharan Africa.
  64. Sexual intercourse, contraception, and abortion: minors' rights and teenagers' behavior in the United States.
  65. Sexuality and contraception in youngs of two precincts of Mexico City.
  66. Sexuality and family planning programme. Health for All 2000.
  67. Sexuality and family planning: report of a consultation and research findings.
  68. Sexuality, contraception, and the media.
  69. Shuangyang County popularizes contraceptive knowledge.
  70. Side effects and discontinuation of oral contraceptive use in southern Brazil.
  71. The significance of oral contraceptive use as a risk factor in cerebrovascular disease. [Zum Stellenwert der oralen Kontrazeptiva als Risikofaktor zerebraler Gefasserkrankungen.]
  72. Sister chromatid exchange in lymphocytes of peripheral blood in women injected with two steroid hormonal contraceptives.
  73. Social and attitudinal determinants of contraceptive choice: using the health belief model.
  74. Social marketing of contraceptives.
  75. Social security, family planning, and fertility: a review of the literature.
  76. Socio-economic correlates of contraceptive knowledge among women in Kuala Lumpur and Petaling Jaya, Malaysia.
  77. The socio-economic determinants of contraceptive use in Jordan.
  78. Socio-economic development of Dongguan County promoted by family planning.
  79. A socio-medical study of fungal and trichomonal changes in vagina among the oral contraceptive users.
  80. Socioeconomic development, family planning and fertility in the People's Republic of China: a subregional analysis.
  81. Sodium pump parameters of red blood cells in men, women and women taking oral contraceptives.
  82. Some perspective on coercion in China's family planning.
  83. Some psychosocial aspects of adolescent sexual and contraceptive behaviors in a changing American society.
  84. Source of service and visit rate of family planning services: United States, 1982.
  85. The South African nurse and family planning.
  86. Specific family planning needs of migrants. [Besoins specifiques des migrants en matiere de planification familiale.]
  87. Sperm maturation and the potential for contraceptive interference.
  88. Spirituality through natural family planning.
  89. Spousal consent for voluntary surgical contraception.
  90. St. Kitts and Nevis. Effect of family life education on knowledge, onset of sexual activity and contraceptive use, 1983-84.
  91. Statistics on contraception and abortion, 1985 (1984) [Statistik om praevention og aborter, 1985 (1984)]
  92. Status of population policy and family planning programme in Kenya.
  93. Status of the uterine mucosa during long-term intrauterine contraception. [Sostoianie slizistoi obolochki matki pri dlitelnoi vnutrimatochnoi kontratseptsii.]
  94. A step towards raising the status of women. Round table on: Family planning and maternal health care: a common goal.
  95. Stepping up primary health care and family planning service delivery through IEC.
  96. Strategies for evaluating a contraceptive service for teenagers.
  97. Strategies for family planning service delivery in Bas Zaire.
  98. Strategies for reducing male opposition to family planning: final report.
  99. The strengthening of family planning training systems in Tunisia: implementation of family planning training activities at the regional level. Subproject proposal.
  100. Strengthening the management of the Korean national family planning program.
  101. Studies on case-control in the framework of research on oral contraceptive side effects. [Eset-kontroll vizsgalatok a fogamzasgatlok mellekhatasainak es kovetkezmenyeinek kutatasaban.]
  102. Studies on ovarian function in users of the progestagen only contraceptive pill.
  103. Studies on psychophysiological performance in female athletes during menstruation without and with hormonal contraceptives. [Untersuchung psychophysiologischer Leistungen im Menstruationszyklus ohne und mit hormonalen Kontrazeptiva bei Sportlerinnen.]
  104. Study explores relationship between early use of oral contraceptives and breast cancer.
  105. A study of dropouts from family planning outlets under the Lusaka Branch of Planned Parenthood Association of Zambia (PPAZ)
  106. Study of family planning and MCH needs in semi-urban slum areas, Turkey, [Hacettepe University, Department of Public Health, WHO Collaborating Center for Research and Research Training in Service Aspects of Family Planning]. Operations research project summary.
  107. A study of new family planning training methods for physicians in Turkey, [Hacettepe University, Department of Public Health, WHO Collaborating Center for Clinical Research and Research Training in Service Aspects of Human Reproduction]
  108. Study of the response of acceptors, to the attributes of Norplant contraceptive subdermal implants and to changes that occur with use of the method. Answers to pre-coded questions. First of a three-part report submitted to the Population Council by CEMICAMP, in fulfillment of Grants No. I85.12A and I86.08A.
  109. A study of the use of model mothers as family planning motivators in a Thai village, [Maternal and Child Health Training Centre, Bangkok]. An on-going research project.
  110. A study of the value of children among acceptor and non-acceptor of family planning devices.
  111. A study on another pregnancy and contraceptive use in postpartum women.
  112. Study on impact and efficiency of family planning program in Korea, final report.
  113. Successful treatment with streptokinase of renal vein thrombosis associated with oral contraceptive use.
  114. Sulfasalazine as a male contraceptive agent.
  115. Summary of Eighteenth National Survey on Family Planning.
  116. Summary of the study of distribution of contraceptive products in Tunisia.
  117. Summary of the Working Meeting on Methodological Issues in Cost-Effectiveness Analysis for Family Planning Programs. Organized by: Tulane University, New Orleans, LA 70112, December 2-4, 1985.
  118. Supporting teenagers' use of contraceptives: a comparison of clinic services.
  119. Survey of male knowledge, attitudes and practice concerning family planning. [Encuesta sobre conocimientos, actitudes y practicas masculinas sobre la planificacion familiar.]
  120. Synthesis and study of contraceptive activity of 8-isoestradiol analogues. [Sintez i issledovanie kontratseptivnoi aktivnosti analogov 8-izozstradiola.]
  121. A systematic evaluation of family life education on contraceptive use and pregnancy among teens. Final report.
  122. Systemic lupus erythematosus, antiphospholipid antibodies, chorea, and oral contraceptives [letter]
  123. Teaching medical students about family planning: experiences from a primary health care course in Lagos, Nigeria.
  124. Technical aspects of intrauterine contraception in difficult cases. [Aspects techniques de la contraception endo-uterine dans les cas difficiles.]
  125. Technical assistance and training in family planning for Senegalese midwives: a trip report.
  126. Technical guidelines for the introduction of Norplant subdermal contraceptive implants [memorandum]
  127. Teenage awareness of family planning matters.
  128. Teenagers and contraception [letter]
  129. Teenagers and contraception [letter]
  130. Teenagers and contraception [letter]
  131. Teenagers and contraception--II.
  132. Teenagers and contraception.
  133. Teenagers and contraception.
  134. Television and contraception.
  135. Tentative discussion on research into family planning psychology.
  136. The terminology of planned parenthood.
  137. Testosterone-estradiol contraception in the male rhesus monkey.
  138. Thromboplastin activity in blood monocytes from oral contraceptive users.
  139. Today's and tomorrow's contraceptives.
  140. Tolnidamine in male contraception: a survey of preclinical data.
  141. Toward a same-day, orally administered male contraceptive.
  142. Towards a women's perspective on family planning.
  143. Toxic shock syndrome and the contraceptive sponge [editorial]
  144. Tradition, development, and the individual: a study of conflicts and supports to family planning in rural Bangladesh.
  145. Traditional family planning practices. [Practicas tradicionales de planificacion familar.]
  146. Training for family planning reception staff.
  147. Training guidelines for voluntary surgical contraception.
  148. Training manual for family planning trainees.
  149. Training traditional medical practitioners for community based distribution in health and family planning in Nepal. Report.
  150. Training, counselling and informational needs for introducing a new contraceptive technology: Norplant implants.
  151. Trends in contraceptive method usage since 1970.
  152. Trials to begin on male contraceptive.
  153. Trip report: JHU/PCS visit to Indonesia. Proposed IEC strategy for the urban family planning program in Indonesia.
  154. Triphasic oral contraceptive as hormone replacement therapy in perimenopausal women.
  155. Tulane family planning operations research in the English speaking Caribbean (Contract AID/DPE-0632-C-00-2007-00)
  156. Turkey: Provision of Family Planning Information and Services in 15 Workplaces. Project proposal.
  157. Two decades of contraceptive research: prospects for the 21st century.
  158. Two strategies for the distribution of contraceptives in factories.
  159. Ultrasonic diagnosis of complications of intrauterine contraception. [Ultrazvukovaia diagnostika oslozhnenii pri vnutrimatochnoi kontratseptsii.]
  160. Ultrasonic evaluation of incrustation on intrauterine contraceptive devices. [Mehen beluli fogamzasgatlo inkrusztacioja, echografiaval kimutatva.]
  161. Ultrasonic monitoring under local anesthesia during removal of an embedded intrauterine contraceptive device.
  162. Unwanted fertility and the demand for family planning services in Northwest Ethiopia.
  163. Update on the metabolic effects of oral contraceptives.
  164. An urban family planning multi-media campaign--a brief to advertising agencies.
  165. Use and misuse of the term potency with respect to oral contraceptives.
  166. Use of contraceptive agents by women in the city of Frunze. [Primenenie protivozachatochnykh sredstv zhenshchinami g. Frunze.]
  167. Use of contraceptives for birth spacing in a Nigerian city.
  168. The use of female school teachers and imams as motivators in family planning services in rural Turkey, [Hacettepe University, Department of Public Health, WHO Collaborating Centre for Research and Research Training in Human Reproduction Operations research project summary.
  169. The use of multidimensional scaling to design, implement and evaluate a family planning education program with primary health care workers in rural Guatemala, [Institute of Nutrition of Central America and Panama]. Operations research project summary.
  170. Use of natural family planning by breastfeeding women.
  171. Use of non-physicians for providing IUD services, Turkey, [Hacettepe University, Department of Public Health, WHO Collaborating Center for Research and Research Training in Service Aspects of Family Planning]. Operations research project summary.
  172. Use of oral contraceptives by women with epilepsy [letter]
  173. Use of oral contraceptives by women with epilepsy [letter]
  174. Use of oral contraceptives by women with epilepsy. In reply [letter]
  175. The use of radio in family planning in Zimbabwe: a case study.
  176. The use of social network analysis for increasing and improving family planning practice in region VI, Philippines.
  177. Using "soap operas" to promote family planning.
  178. Vaginal carriage of anaerobic motile curved rods: relation to contraceptive practice, common pathogens, signs and symptoms.
  179. Vaginal contraception with the Today sponge and the Benzaltex sponge (Pharmatex sponge) [Vaginale Kontrazeption mit Today- und Benzaltex-Tampons.]
  180. The vaginal contraceptive pill.
  181. Vaginal contraceptives still evolving.
  182. Vaginal contraceptives: worldwide use remains low but methods have potential.
  183. Variation in the levels of calcium, copper, iron, magnesium, manganese and zinc in normal and pathological smooth uterine muscle and its relation to the use of oral contraceptives. [Variacion de los niveles de calcio, cobre, hierro, magnesio, manganeso y zinc, en el musculo liso uterino normal y patologico y su asociacion con el uso de anticonceptivos orales.]
  184. The venous bloodstream under the influence of hormonal contraceptive agents. [Die venose Blutstromung unter dem Einfluss hormonaler Kontrazeptiva.]
  185. Venous thromboembolic disease and oral contraceptives. [Venos trombo-embolisk sygdom og p-piller.]
  186. Vesicouterine fistula with menouria: a complication from an intrauterine contraceptive device.
  187. Vitamin B-6 requirements and oral contraceptive use--a concern?
  188. In vitro quantitative adherence of microorganisms to intrauterine contraceptive devices.
  189. In vitro testing of Today vaginal contraceptive sponge with bacteria.
  190. Voluntarism in the Bangladesh family planning program.
  191. Weight gain in adolescent and young adult oral contraceptive users.
  192. What college students want to learn about contraception/STD: marketing your services.
  193. What contraceptive revolution? [letter]
  194. What Malians say about family planning. Results of group interviews, March 1986. [Ce que les Maliens disent a propos du planning familial. (Resultats des interviews du groupe), Mars 1986.]
  195. When high schools offer family planning.
  196. Who has the right to advise children on birth control?
  197. Why not use contraception? Economics of fertility regulation among rural Egyptian women.
  198. Why people desiring birth control still do not use contraception.
  199. Why some women fail to use their contraceptive method: a psychological investigation.
  200. Will hiring more FWA affect contraceptive prevalence in rural Bangladesh? -- analytical evidence from the MCH-FP Extension Project.
  201. With firm resolve: family planning in China.

     

  202. Withdrawal of the intrauterine contraceptive devices from the U.S. market and its effect on Asian countries' family planning program.
  203. Women's motivation for family planning in Kisii District: potentials and barriers.
  204. Worker-client exchanges and the dynamics of contraceptive use in rural Bangladesh.
  205. Workplace Family Planning and Child Care Education Services Project [Turkey]. Project description.
  206. Worldwide panorama of integrated family planning projects. In search of family planning that will be well accepted by the people. Antecedents and advances. [Panorama mundial de los proyectos integrados de planeacion familiar. En busca de una planeacion familiar que sea bien aceptada por la gente. Antecedentes y avances.]
  207. Yugoslavian experience with the contraceptive sponge.
  208. Zimbabwe National Family Planning Council [ZNFPC]: an analysis of ZNFPC's IEC inputs in population programs.
  209. Actinomyces and the intrauterine contraceptive device: aspects of the fluorescent antibody stain.
  210. Adolescent contraception: an update.
  211. Alterations of cervical cytology and steroid contraceptive use.
  212. Are we failing our teenagers? Value of a family planning service for teenagers within the sexually transmitted disease clinic.
  213. Association of Actinomyces and intrauterine contraceptive devices.
  214. Breast cancer and depot-medroxyprogesterone acetate. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
  215. Breast cancer and oral contraceptives [letter]
  216. Cervical Chlamydia trachomatis infection in university women: relationship to history, contraception, ectopy, and cervicitis.
  217. Cervical dysplasia: association with sexual behavior, smoking, and oral contraceptive use?
  218. Changes in contraceptive practice since October 1983 in a Portsmouth family planning clinic.
  219. The changing attitude and practice of men regarding family planning in Lagos, Nigeria.
  220. Chlamydia trachomatis infection at a family planning clinic.
  221. Clinical chemistry alterations in pregnancy and oral contraceptive use.
  222. Collagen sponge as vaginal contraceptive barrier: critical summary of seven years of research.
  223. A comparative clinical trial of the contraceptive sponge and Neo Sampoon tablets.
  224. Contraception and decision-making.
  225. Contraception with long-acting subdermal implants. A five-year clinical trial with silastic covered rod implants containing levonorgestrel.
  226. Contraception with subdermal ST-1435 capsules: side-effects, endocrine profiles and liver function related to different lengths of capsules.
  227. Contraceptive usage during lactation: analysis of 1973 and 1976 National Survey of Family Growth: I. Age and race.
  228. Contraceptive use among women in Kuwait.
  229. Contraceptive use among women with sickle cell diseases, Accra, Ghana.
  230. Contraceptive use in Canada, 1984.
  231. Contraceptive use in Georgia: estimation by telephone survey.
  232. Contraceptive use, pregnancy and fertility patterns among single American women in their 20s.
  233. Copper intrauterine contraceptive device insertion 6 weeks after caesarean section.
  234. Deep vein thrombosis and the oestrogen content in oral contraceptives--an epidemiological analysis.
  235. The effect of altered prednisolone kinetics in patients with the nephrotic syndrome and in women taking oral contraceptive steroids on human mixed lymphocyte cultures.
  236. Effect of long-term hormonal contraception on plasma lipids.
  237. The effect of oral medroxyprogesterone acetate and methyltestosterone on sexual functioning in a male contraceptive trial.
  238. The effects of low-dose oral contraceptives on coagulation and fibrinolysis in two high-risk populations: young female smokers and older premenopausal women.
  239. Ethynyl-estradiol (EE-2) retained in blood and endometrium during and after steroidal contraception.
  240. Family planning clinic services in the United States, 1983.
  241. Fertility regulation in nursing women: VIII. Progesterone plasma levels and contraceptive efficacy of a progesterone-releasing vaginal ring.
  242. Fluctuations in quantitative features of intermediate cells in normal cervical smears during the menstrual cycle of ovulating women and contraceptive users.
  243. Group B-beta haemolytic streptococcal colonization in women using intrauterine contraceptive devices.
  244. Hormonal contraception in diabetic women: acceptability and influence on diabetes control and ovarian function of a nonalkylated estrogen/progestogen compound.
  245. Hormonal contraceptive card--an innovative concept of improved follow-up. [Der Ausweis bei Einnahme hormonaler Kontrazeptiva--eine Moglichkeit zur verbesserten Betreuung.]
  246. Hospitalizations among black women using contraceptives.
  247. Hyperprolactinemia and contraception: a prospective study.
  248. The influence of client-provider relationships on teenage women's subsequent use of contraception.
  249. Influence of levonorgestrel contraceptive implants, NORPLANT, initiated early postpartum upon lactation and infant growth.
  250. Influence of levonorgestrel contraceptive implants, Norplant, initiated early postpartum upon lactation and infant growth.
  251. The influence of oral contraceptives on the postmolar human chorionic gonadotropin regression curve.
  252. Influence of oral contraceptives on the prognosis of breast cancer in young women.
  253. Interaction of anticonvulsants and oral contraceptives in epileptic adolescents.
  254. Invasive cervical cancer and depot-medroxyprogesterone acetate. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.
  255. Iron stores in users of oral contraceptive agents.
  256. Long-term use of oral contraceptives and cervical neoplasia: an association confounded by other risk factors?
  257. Low-dose oral contraception and blood pressure in women with a past history of elevated blood pressure.
  258. Lymphocyte subsets in women on low dose oral contraceptives.
  259. Measurement of breast volume by ultrasound during normal menstrual cycles and with oral contraceptive use.
  260. Microbiology of the lower genital tract in postmenarcheal adolescent girls: differences by sexual activity, contraception, and presence of nonspecific vaginitis.
  261. Oral contraceptives and cardiovascular disease: a critique of the epidemiologic studies.
  262. Oral contraceptives, Chlamydia trachomatis infection, and pelvic inflammatory disease. A word of caution about protection.
  263. Oral contraceptives, lipids and cardiovascular disease.
  264. Phase II randomized clinical trial with norethisterone oenanthate 50 mg alone and in combination with 5 mg or 2.5 mg of either estradiol valerate or cypionate as a monthly injectable contraceptive.
  265. Progestogen-only oral contraception. Findings in a large prospective study with special reference to effectiveness.
  266. A prospective study of drug use, smoking and contraceptives during early pregnancy.
  267. Public funding of contraceptive, sterilization and abortion services, 1983.
  268. A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic parameters: I. Effects upon sexual hormone levels.
  269. A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic serum parameters: II. Effects upon thyroid function, gastrin, STH, and glucose tolerance.
  270. A randomized crossover comparison of two low-dose contraceptives: effects on serum lipids and lipoproteins.
  271. A randomized double-blind study of the effects of two low-dose combined oral contraceptives on biochemical aspects: report from a seven-centred study. WHO Special Programme of Research, Development and Research Training in Human Reproduction. Task Force on Oral Contraceptives.
  272. Relative potency of progestins used in oral contraceptives.
  273. Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada Melanoma Study.
  274. Return to ovulation following the use of long-acting injectable contraceptives: a comparative study.
  275. Safety of the contraceptive pill--a 24-year trial [letter]
  276. Serum gonadotropin and ovarian steroid levels in women during administration of a norethindrone-ethinylestradiol triphasic oral contraceptive.
  277. Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel.
  278. Seven years clinical experience of the injectable contraceptive norethisterone oenanthate.
  279. Side and site of deep vein thrombosis in women using oral contraceptives.
  280. Side effects of oral contraceptive use in lactating women--enlargement of breast in a breast-fed child.
  281. Spironolactone in combination with an oral contraceptive: an alternative treatment for hirsutism.
  282. Sulpiride and the potentiation of progestogen only contraception.
  283. Triphasic oral contraception: metabolic effects in normal women and those with previous gestational diabetes.
  284. Ultrasound demonstration of increased frequency of functional ovarian cysts in women using progestogen-only oral contraception.
  285. Use of the Today contraceptive sponge in the United States.
  286. Vaginal administration of a combined oral contraceptive containing norethisterone acetate.
  287. Vitamin supplements to Indian women using low dosage oral contraceptives.
  288. Contraceptive social marketing: lessons from experience./O marketing social de anticoncepcionals: licoes a partir da experencia./Le marketing social des contraceptifs : les lecons de l'experience./Mercadeo social de anticonceptivos: lecciones de la experencia.
  289. The impact of family planning programs on fertility./Impacto dos programas de planejamento familiar sobre a fecundidade./L'enfluence des programmes familial sur la fecondite./El efecto de los programas de planificacion familiar en la fecundidad.
  290. Fertility and family planning surveys: an update./Levantamentos sobre fecundidad e planejamento familiar: uma atualzacao./Actualizacion de las encuestas de fecundidad de planificacion familiar./Enquetes sur la fecondite et sur le planning familial : elements nouveaux.
  291. Family planning programs and fertility decline in Taiwan and mainland China: a comparison.
  292. Family planning programs in agrarian societies: lactation contraception and its policy implications.
  293. Family planning programs in developed countries.
  294. Family planning programs: the clients' perspective.
  295. Family planning service in Nigeria.
  296. Family planning services for industrial workers. Project description.
  297. Family planning services for police, armed forces.
  298. Family planning social marketing programs--their impact on the contraceptive market.
  299. Family planning through child health: a case study of El Kef project in Tunisia.
  300. Family planning, fertility and family health in Haiti, 1983, report of the results of a Haitian survey on contraceptives prevalence. [Planification familiale, fecondite et sante familiale en Haiti 1983, rapport sur les resultats de l'enquete Haitienne sur la prevalence de la contraception.]
  301. Family planning, fertility and family health in Morocco 1983-84. Report of the National Contraceptive Prevalence Survey. [Planification familiale, fecondite et sante familiale au Maroc 1983-84. Rapport de l'Enquete Nationale de Prevalence Contraceptive.]
  302. Family planning, fertility and family health in Zaire. Report on the findings of regional contraceptive prevalence survey. [Planification familiale, fecondite et sante familiale au Zaire 1982-1984. Rapport sur les resultats d'une enquete regionale sur la prevalence contraceptive.]
  303. Family planning, fertility, and family health in Zaire. A report on the results of a regional survey on the prevalence of co. [Planification familiale, fecondite et sante familiale au Zaire. Rapport sur les resultats d'une enquete regionale sur la prevalence contraceptive en 1982-1984.]
  304. Family planning, nutrition and primary health care for Africa: program design, management, and evaluation: workshop syllabus and schedule, June 3-28, 1985.
  305. Family planning-information, education and communication (FP -IEC) master plan, fourth five year plan.
  306. Family planning.
  307. Family planning.
  308. Family planning: a population study of women aged 40-44 years.
  309. Family planning: a report. Communications to narrow the gap.
  310. Family planning: facilities surveyed.
  311. Family planning: general practice and clinic services.
  312. Family planning: knowledge, attitude and practice of childbearing women in rural areas.
  313. Family planning: the Chinese Embassy replies. [letter]
  314. Family planning: the global challenge.
  315. Features of the endometrial mitotic regime in various periods of use of intrauterine contraceptives. [Osobennosti mitoticheskogo rezhima endometriia pri razlichnykh srokakh perimeneniia vnutrimatochnykh kontratseptivov.]
  316. Female education, family planning, income and population: a long-run econometric simulation model.
  317. A female patient with large liver tumor and long-term intake of oral contraceptives. [Eine Patientin mit grossem Lebertumor und langjahriger Einnahme oraler Kontrazeptiva.]
  318. Female status as a determinant of contraceptive use.
  319. Female voluntary surgical contraception under the Ministry of Health, 1981-1984. [Anticoncepcion femenina por cirugia voluntaria, en la Secretaria de Salud, 1981-1984.]
  320. Fenpyramine in the prevention of some side effects of intrauterine contraception. [La fenpiramina nella prevenzione di alcuni effetti collaterali della contraccezione intrauterina.]
  321. Fertility and family planning among white collar workers.
  322. Fertility and family planning in Egypt 1984.
  323. Fertility and family planning in Tunisia, 1983, report of the results of the Tunisian Contraceptive Prevalence Survey. [Fecondite et planification familiale en Tunisie, 1983, rapport sur les resultats de l'enquete Tunisienne sur la prevalence de la contraception.]
  324. Fertility and family planning in urban Somalia: results of the Somali Family Health Survey in five cities, 1983.
  325. Fertility and modern family planning in rural southwestern Nigeria.
  326. More male responsibility or more equal responsibility? Teenagers and their use of contraception.
  327. Mortality, fertility and family planning: Dominica and St. Lucia.
  328. The most neglected intimacy -- birth control. How to shorten the responsibility gap between men and women.
  329. Motivational factors that determine the non-use of contraceptives.
  330. Multilevel effects of socioeconomic development and family planning programs on children ever born.
  331. Multivariate areal analysis of the efficiency of family planning programme and its impact on fertility in Peninsular Malaysia.
  332. Na+-Li+ countertransport in human erythrocytes--effects of hypokalaemia, oral contraceptives and antihypertensive medication.
  333. National Family Planning Program 1985-1988. [Programa Nacional de Planificacion Familiar 1985-1988.]
  334. The national family planning program in Indonesia; role of the intrauterine contraceptive device.
  335. National NGOs in Asia provide leadership for voluntary surgical contraception.
  336. National pharmacy family planning information service proposed.
  337. Natural family planning acceptors in an operational research project in Kenya: preliminary data.
  338. Natural family planning after pregnancy. A problem for women with previously irregular menstrual cycles.
  339. Natural family planning in 1985: a status report.
  340. Natural family planning.
  341. Natural family planning.
  342. Natural family planning.
  343. Natural family planning: international development, present status, future prospects. [Naturliche Familienplanung: Internationale Entwicklung, derzeitiger Stand, Zukunftsaspekte.]
  344. Natural family planning: introduction and epidemiological studies. [Naturliche Familienplanung: einfuhrung und epidemiologische Untersuchungen.]
  345. Natural methods of birth control. [Les methodes naturelles de regulation des naissances.]
  346. Natural regulation of conception and contraception.
  347. Nature's contraceptive.
  348. The need for ovulation detection before prescribing oral contraception.
  349. The Netherlands' co-operation policy in the field of population and family planning.
  350. New advances in contraception and sterilization. [Nuevos avances en contracepcion y esterilizacion.]
  351. New aspects in post-coital contraception.
  352. New contraceptive agent: various questions on p-sponges. [Nytt preventivmedel: nagra fragor runt p-kudden.]
  353. New developments in postovulatory methods of birth control.
  354. The next contraceptive revolution.
  355. Noncompliance among oral contraceptive acceptors in rural Bangladesh.
  356. Noncompliance in screening follow-up among family planning clinic patients with cervical dysplasia.
  357. Nonprescription contraceptives: increasing in popularity.
  358. Norplant contraceptive implants: a new contraceptive for women.
  359. Norplant contraceptive implants: instructions for insertion and removal.
  360. Not wanting children yet not practising family planning--a qualitative assessment.
  361. The abnormal haemoglobins reproduction and family planning.
  362. The acceptability of new contraceptive methods for men.
  363. The acceptance of modern family planning in rural Nigeria: the Oyo State Community-based Health/Family Planning Program in southwestern Nigeria.
  364. Acceptance of sexuality as a factor in older adolescent females' knowledge of reproduction and use of contraception.
  365. Access to health and family planning services in rural Uttar Pradesh: a micro level evaluation.
  366. ACOG contraceptive spot rejected.
  367. An Act (No. 1 of 1985) to establish the Zimbabwe National Family Planning Council and to provide for the structure, functions and powers thereof.
  368. Actinomyces and the intrauterine contraceptive device.
  369. Acute and intermittent LHRH agonist dosing as post-coital and anti-ovulatory contraceptive approaches.
  370. Addressing the problem of outcome evaluation in family planning [revised draft]
  371. Addressing the problem of outcome evaluation in family planning.
  372. Adolescent contraception. [La contraception chez l'adolescente.]
  373. Adolescent contraception: helping the adolescent choose a method of birth control.
  374. Adolescent contraceptive behavior: a review.
  375. Adolescents' competency to make informed birth control and pregnancy decisions: an interface for psychology and the law.
  376. Adolescents' values, sexuality, and contraception in a rural New York county.
  377. Adolescents: planning contraceptive and counselling services.
  378. Advanced family planning training for nurses: family planning services project, Kinshasa--Zaire.
  379. Advances in drug delivery: modern drug delivery systems for contraception.
  380. Advantages and disadvantages of low-dose hormonal contraceptive agents.
  381. Age variation in use of a contraceptive service by adolescents.
  382. Age, gender and ethnic differences in sexual and contraceptive knowledge, attitude, and behavior of 16-25 year old Whites, Blacks, Hispanics, and Asians.
  383. Age, gender, and ethnic differences in sexual and contraceptive knowledge, attitudes, and behaviors.
  384. The ageing gamete in relation to birth control failures and Down syndrome.
  385. Aggravation of sideracrestic anemia following the administration of oral contraceptives. [Agravacion de la anemia sideroacrestica tras la ingesta de anticonceptivos orales.]
  386. Agreement, concordance and predictability of parent-child responses to sex and family planning issues in a national survey sample.
  387. AID's experience with contraceptive social marketing; a synthesis of project evaluation findings.
  388. Allosensitization in tumor therapy and prophylaxis, and in female contraception--a prospect for clinical use.
  389. Altered erythrocyte cation transport related to hypertension or oral contraception.
  390. American physicians and birth control, 1936-1947.

     

  391. Analysis of service statistics and family planning acceptance in the Oyo State CBD project.
  392. Analysis of the recent decision by China's State Family Planning Commission to separate the delivery of family planning services from other health care services.
  393. Analysis--of family-planning in urban low-income brackets based on Daejon and Daegu Cities.
  394. And they call it "rhythm". The practice of periodic abstinence in Bicol and the Visayas regions. A report based on the 1984 Natural Family Planning Survey.
  395. Antibiotic- and anticonvulsant-induced oral contraceptive failure.
  396. Apoplectic leiomyomas of the uterus: a clinicopathologic study of five distinctive hemorrhagic leiomyomas associated with oral contraceptive usage.
  397. Applying information to improve family planning in Gaoping County.
  398. Artistic visions of family planning.
  399. Aspects of family planning and migration: report on two surveys.
  400. Assessing the characteristics and cost-effectiveness of contraceptive methods.
  401. An assessment of the effectiveness of educational efforts in a community-based health/family planning program.
  402. An assessment of the Metro Manila Family Planning Outreach Project.
  403. Assessment of the Operations Research Project and future operations research needs in family planning in Haiti.
  404. Attitude to practise family planning methods.
  405. Attitudes toward contraception.
  406. Bacterial flora in genital organs of women using intrauterine contraceptive devices of the Copper T-200 type. [Flora bakteryjna w narzadzie rodnym kobiet noszacych antykoncepcyjne wkladki wewnatrzmaciczne typu Copper T-200.]
  407. Bangladesh Contraceptive Prevalence Survey--1983. Final report.
  408. The Barbados male family planning survey country report 1982.
  409. Barrier contraception in the teenager: a comparison of four methods in adolescent girls.
  410. Barrier methods of contraception.
  411. Barrier methods of contraception.
  412. Barrier methods of contraception.
  413. Barrier methods of contraception.
  414. Barriers to effective family planning in Nepal.
  415. The benefits of oral contraceptives.
  416. Benefits that management may derive from FP. Based on the study of employee benefits for family planning in rural-based industries.
  417. Beyond family planning. Part 1.
  418. Beyond family planning. Part 2.
  419. Beyond family planning: a plea for integrated population education with special reference to India.
  420. Beyond family planning: case study of the Village Family Planning / Mother Child Welfare Project, USAID / Jakarta.
  421. Bibliography on population and family planning in Korea: 1981-1984.
  422. The bioavailability of contraceptive steroids in patients with cystic fibrosis.
  423. Biochemical aspects of a contraception model based on immunological properties of proteohormones.
  424. Biological evaluation of some medicinal plant extracts for contraceptive efficacy in females. [Evaluation biologique de l'efficacite de l'action contraceptive d'extraits de certaines plantes medicinales chez la femme.]
  425. Birth control knowledge, attitudes and practice: a comparison of working and middle class Puerto Rican and white American women.
  426. Birth control methods and organisation in China.
  427. Birth control use by teenagers: one and two years postabortion.
  428. Birth-control trip-ups. How to avoid just-this-once risks.
  429. Breast cancer and oral contraceptives [letter]
  430. Breast cancer and oral contraceptives: a review.
  431. Breast feeding--the leading contraceptive in the world. [Amning - varldens ledande preventivmedel.]
  432. Breast-feeding: nature's contraceptive.
  433. Breastfeeding and contraception: why the inverse association?
  434. Breastfeeding and the use of contraceptives.
  435. Breastfeeding, contraception, and birth intervals in developing countries.
  436. A broadcast on family planning in Hefeng County.
  437. Cancers of the uterus and ovary and the contraceptive pill. [Cancers de l'uterus et de l'ovaire et pilule contraceptive.]
  438. Cardiovascular complications, lipoprotein metabolism and oral contraceptives. [Les complications cardiovasculaires, le metabolisme des lipoproteines et les contraceptifs oraux.]
  439. The caring male. Report of a National Conference on Male Involvement in Family Planning.
  440. Carpal tunnel syndrome caused by oral contraceptives (letter) [Sindrome del tunel carpiano causado por anticonceptivos orales [letter]]
  441. The case for birth control before 1850: Nantucket reexamined.
  442. A case of birth control before 1800: Gemenos, 1700-1790. [Un cas de malthusianisme avant 1800: Gemenos 1700-1790.]
  443. Case-control study of galactorrhea and its relationship to the use of oral contraceptives.
  444. The cervical cap as a contraceptive alternative.
  445. The cervix and hormonal contraception. [Col uterin et contraception hormonale.]
  446. Challenges to international and domestic family planning. Under the guise of opposition to abortion.
  447. Changes in blood coagulation during hormonal contraception. [Veranderungen der Blutgerinnung bei hormonaler Kontrazeption.]
  448. Changes in fertility and contraception in Mexico, 1977-1982.
  449. Changing concepts of family planning programmes and methodological implications for evaluation.
  450. The changing pattern of contraception in Lahore, Pakistan: 1963-80.
  451. Characteristics of family planning acceptors at a primary health care project in Lagos, Nigeria.
  452. Chemistry, contraceptive activity and toxicology of aryl guanidinobenzoates: inhibitors of sperm acrosin.
  453. Child health and family planning.
  454. Child spacing and family planning: CBD procedure manual.
  455. China goes at family planning her own way: an account of 35 years of family planning.
  456. China's birth control policy drives some to kill baby girls.
  457. Choice of a progestagen for contraception. [Choix d'un progestatif en contraception.]
  458. Choice of contraception in connection with the closing of a contraception clinic. Results of an anonymous questionnaire answered by 401 women. [Valg af kontraception i relation til lukning af svangerskabsforebyggende klinik. En konsekutiv anonym sporgeskemaundersogelse af 401 kvinder.]
  459. The choice of contraceptive method: estimation of the economic model.
  460. Choosing contraception for adolescents. [Quelle contraception pour les adolescentes?]
  461. Chromium status: effects of demographic characteristics, oral contraceptive agents and chromium supplementation.
  462. Chromosomal abnormalities in the Kaiser-Permanente Birth Defects Study, with special reference to contraceptive use around the time of conception.
  463. Clinical and pathological comparison of young adult women with hepatocellular carcinoma with and without exposure to oral contraceptives.
  464. Clinical assessment of a new triphasic oral contraceptive.
  465. A clinical study on injectable contraceptive Noristerat.
  466. Clinical trials of the new injectable contraceptive noristerat: a study of 1000 cases. [Essai clinique d'un nouveau contraceptif injectable (le noristerat) a propos de 1000 cas.]
  467. Closing views and critical comments on natural family planning. [Schlussbetrachtung und kritische Bemerkungen zur naturlichen Familienplanung.]
  468. The coherence hypothesis of birth control use: the relationship between preferences, chosen method, and the consistency of birth control use.
  469. Coital rates, age and method of contraception: results of a BJSM pilot questionnaire survey.
  470. Combined oral contraceptive pills.
  471. Comment: contraception dilemmas for the relatively infertile.
  472. Comments on Canadian planned parenthood article.
  473. Comments on: "Summary views on the economics of family planning in Bangladesh; by George Simmons, Obaidur Rob.
  474. Communication and contraceptive practices in adolescent couples.
  475. Communication in adoption of family planning.
  476. Communication skills and family planning doctors.
  477. Community and individual acceptance: family planning services in the Sudan.
  478. Community based distribution of contraceptives: experiences of Tenwek Hospital; Bomet, Kenya. A report after one year of involvement.
  479. Community distribution of contraceptives in rural areas of Colombia. Final narrative report.
  480. Community effects on contraceptive use in the Philippines.
  481. Community effects on contraceptive use.
  482. Community factors in contraception among Bangladeshi women.
  483. Community-based delivery of primary health care and family planning services: an historical and global overview.
  484. Community-based distribution of low-cost family planning and maternal and child health services in rural Nigeria.
  485. Community-oriented health, nutrition and family planning services: overview and lessons from operations research.
  486. Comparative metabolic effects of oral contraceptive preparations containing different progestagens--effects of desogestrel and ethinylestradiol on the haemostatic balance.
  487. A comparison of 1970 and 1980 survey findings on family planning in India.
  488. A comparison of census and family planning program data on contraceptive prevalence, Indonesia.
  489. A comparison of the actual and expected pain response following insertion of an intrauterine contraceptive device.
  490. Comparison of the effects of confluent vs traditional contraceptive education on young people's knowledge, attitudes and behaviors.
  491. Completing the circle: three generations of intrauterine contraception.
  492. Complications of contraception with the intrauterine coil. [Niakoi uslozhneniia pri kontratseptsiia s v utrematochna spirala.]
  493. The concept of potential fertility in evaluation of the fertility impact of family planning programmes.
  494. Conference on the Oyo State CBD project: community-based delivery of health and family planning services [proceedings], University of Ibadan Conference Center, January 14-16, 1985, Ibadan, Nigeria.
  495. Continuation and effectiveness of contraceptive practice: a cross-sectional approach.
  496. Contraception and marital love.
  497. Contraception and pelvic inflammatory disease. [Anticoncepcion y enfermedad inflamatoria pelvica.]
  498. Contraception and personality (letter) [Contraccezione e personalita.]
  499. Contraception and subsequent fertility. Results of a retrospective study. [Contraception et fertilite ulterieure. Resultats d'une enquete retrospective.]
  500. Contraception and the desire for pregnancy in the adolescent. [Contraccezione e desiderio di gravidanza nell'adolescente.]

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.